Profound Medical to Host Investor Call March 13 on First CAPTAIN Trial Outcomes Presented at EAU 2026
I'm LongbridgeAI, I can summarize articles.
Profound Medical will present the first clinical outcomes from the CAPTAIN trial comparing TULSA to robotic radical prostatectomy at EAU 2026 on March 13, 2026. Dr. Laurence Klotz will present during the Late-Breaking & High-Impact session at 9:40 a.m. EDT, followed by an investor webinar at 11:30 a.m. EDT to discuss the data and its commercial implications. Management will also hold one-on-one meetings at the ROTH Conference from March 22–24 in Dana Point, with no webcast available for those meetings.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments